Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Psychol Med. 2011 Nov 1;42(6):1151–1162. doi: 10.1017/S003329171100239X

Table 3.

Suggestive GWAS results with q values between 0.05 and 0.10

Outcome
Locus
Test
Drug Measure SNPID Gene Chr Psn (bp) MAF MA n p value q value EFF
Bupropion General SE rs10857636 WDFY4 10 49655116 0.06 T 126 1.64 × 10−7 0.069 −
Bupropion Sex rs17150687 MAGI2 7 77881227 0.02 C 128 2.76 × 10−6 0.097 −
Citalopram + Bupropion Vision/hearing rs10517287 4 33301097 0.11 T 160 1.62 × 10−7 0.068 −
Citalopram + Bupropion Vision/hearing rs17647114 AGBL1 15 85237749 0.03 T 158 3.86 × 10−7 0.081 +
Citalopram + Buspirone Dizziness rs16861531 2 14315503 0.03 G 152 6.90 × 10−7 0.069 +
Citalopram + Buspirone Dizziness rs6795349 CHL1 3 147477 0.03 G 149 2.28 × 10−6 0.080 +
Citalopram + Buspirone Dizziness rs491376 4 12725860 0.01 C 150 1.58 × 10−6 0.069 +
Citalopram + Buspirone Dizziness rs573332 4 12731633 0.11 G 152 1.47 × 10−6 0.069 +
Citalopram + Buspirone Dizziness rs2163287 ZDHHC14 6 157961271 0.02 A 151 2.84 × 10−6 0.087 +
Citalopram + Buspirone Dizziness rs7015622 8 84066369 0.01 C 152 1.47 × 10−6 0.069 +
Citalopram + Buspirone Dizziness rs7016317 8 84066573 0.01 G 152 1.47 × 10−6 0.069 +
Citalopram + Buspirone Dizziness rs10988449 C9orf50 9 131410181 0.17 T 152 2.90 × 10−6 0.087 +
Citalopram + Buspirone Dizziness rs8039808 DTWD1 15 47727138 0.06 A 152 4.92 × 10−7 0.069 +
Citalopram + Buspirone Dizziness rs10519235 DTWD1 15 47733664 0.06 T 152 4.92 × 10−7 0.069 +
Citalopram + Buspirone Dizziness rs10519238 DTWD1 15 47756591 0.05 T 152 7.19 × 10−7 0.069 +
Citalopram + Buspirone Dizziness rs2034588 16 8269328 0.02 G 152 1.64 × 10−6 0.069 +
Citalopram + Buspirone Dizziness rs12157904 LGALS2 22 36311958 0.07 G 152 2.11 × 10−6 0.080 +
Citalopram + Buspirone Dizziness rs16990008 DMD 23 31925297 0.02 C 152 1.60 × 10−6 0.069 +
Citalopram + Buspirone General SE rs527430 FOXD2 1 47691408 0.39 G 152 3.52 × 10−7 0.074 +
Citalopram + Buspirone General SE rs17766217 POU5F1B 8 128573679 0.01 A 151 2.52 × 10−7 0.074 +
Sertraline General SE rs6724422 2 67830292 0.06 T 113 3.74 × 10−7 0.079 +
Venlafaxine Dizziness rs11949289 5 28375930 0.42 T 135 2.19 × 10−7 0.092 +

GWAS, Genome-wide association study ; SNP, single nucleotide polymorphism; Chr, chromosome number; Psn, position ; MAF, minor allele frequency ; MA, minor allele; n, sample size; Eff, direction of the effect of minor allele ; SE, side-effect.

Locus information includes Chr and location of SNP (bp, Genome Build 35). For each test, we report n, Eff, where a ‘+’ means a higher factor score, and the p and q values of the test. Shaded rows indicate SNPs in high linkage disequilibrium (LD; r2>0.8) with each other.